BioRestorative Therapies BRTX
NASDAQ BRTX
$1.57 +0.02 (+1.29%)
As of: Nov 11, 2026 · 3:59 PM EST

BioRestorative Therapies (BRTX) Payables (2010 - 2026)

Updated

BioRestorative Therapies (BRTX) recorded Payables of $666,898 in Q1 2026, up 11.2% from $599,500 a year earlier but down 50.3% from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Payables (2010 - 2026) Analysis & Trends

At the end of FY2025, BioRestorative Therapies reported Payables of $1.34 million, up 177.7% from FY2024.

  • Annual Payables has increased for four straight years, with a five-year compound annual growth rate of 62.4% (FY2020 to FY2025).
  • Across earlier years, Payables came in at $483,070 in FY2024 (+155.1%), $189,389 in FY2023 (+10.8%), $170,902 in FY2022 (+236.2%) and $50,827 in FY2021 (-57.2%).
  • Quarterly Payables has ranged from $50,827 in Q4 2021 to $1.34 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Payables has increased for seven consecutive quarters, with growth averaging 106.9% over the last eight quarters.
  • Peak year-over-year performance for Payables in the last five years was growth of 287.2% in Q2 2022, against a decline of 57.2% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.34 million (Q4 2025), $859,898 (Q3 2025) and $609,931 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.17 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 34.43 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 7.17 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -25.19 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 934.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.07 Bn
10 BioRestorative Therapies 1.36 Mn -17.06 Mn 15,785.00 666,898.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 666,898.00
Dec 31, 2025 1.34 Mn
Sep 30, 2025 859,898.00
Jun 30, 2025 609,931.00
Mar 31, 2025 599,500.00
Dec 31, 2024 483,070.00
Sep 30, 2024 401,379.00
Jun 30, 2024 215,920.00
Mar 31, 2024 230,902.00
Dec 31, 2023 189,389.00
Sep 30, 2023 227,355.00
Jun 30, 2023 276,048.00
Mar 31, 2023 92,586.00
Dec 31, 2022 170,902.00
Sep 30, 2022 468,501.00
Jun 30, 2022 378,233.00
Mar 31, 2022 213,893.00
Dec 31, 2021 50,827.00
Sep 30, 2021 124,558.00
Jun 30, 2021 97,692.00
API Access

BioRestorative Therapies Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=BRTX&period=max&api_key=YOUR_API_KEY